These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 29290527

  • 1. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Nakai H, Sato T, Uno T, Furukawa E, Kawamura M, Takahashi H, Watanabe A, Fujimura S.
    J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
    [Abstract] [Full Text] [Related]

  • 2. [Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children].
    Tian HL, Shi W, Zhou HF, Yuan L, Yao KH, Rexiati D, Xu AM.
    Zhonghua Er Ke Za Zhi; 2018 Apr 02; 56(4):279-283. PubMed ID: 29614568
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017.
    Nagai K, Kimura O, Domon H, Maekawa T, Yonezawa D, Terao Y.
    J Infect Chemother; 2019 Mar 02; 25(3):229-232. PubMed ID: 30279114
    [Abstract] [Full Text] [Related]

  • 4. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN, Fritsche TR, Sader HS, Stilwell MG.
    Diagn Microbiol Infect Dis; 2007 May 02; 58(1):9-17. PubMed ID: 17408903
    [Abstract] [Full Text] [Related]

  • 5. Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens.
    Hermsen ED, Hovde LB, Konstantinides GN, Rotschafer JC.
    Antimicrob Agents Chemother; 2005 Apr 02; 49(4):1633-5. PubMed ID: 15793158
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y.
    Diagn Microbiol Infect Dis; 2012 Jun 02; 73(2):187-91. PubMed ID: 22521692
    [Abstract] [Full Text] [Related]

  • 7. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA, Farrell DJ, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep 02; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases.
    Suzuki K, Fujisawa T, Nakashima M, Hamasaki R.
    J Infect Chemother; 2005 Oct 02; 11(5):253-5. PubMed ID: 16258823
    [Abstract] [Full Text] [Related]

  • 9. Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001).
    Jones RN, Biedenbach DJ.
    Diagn Microbiol Infect Dis; 2003 Apr 02; 45(4):273-8. PubMed ID: 12729999
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F, Carnegy F, Willcock J, Amyes S.
    J Antimicrob Chemother; 2004 May 02; 53(5):793-6. PubMed ID: 15056640
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A.
    East Mediterr Health J; 2005 May 02; 11(1-2):36-44. PubMed ID: 16532669
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance.
    Richard MP, Aguado AG, Mattina R, Marre R.
    J Antimicrob Chemother; 1998 Feb 02; 41(2):207-14. PubMed ID: 9533462
    [Abstract] [Full Text] [Related]

  • 13. Selection of resistant variants of respiratory pathogens by quinolones.
    Sefton AM, Maskell JP, Williams JD.
    Int J Antimicrob Agents; 1999 Jul 02; 12(2):129-34. PubMed ID: 10418757
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992.
    Gómez J, Ruiz-Gómez J, Hernández-Cardona JL, Núñez ML, Canteras M, Valdés M.
    Chemotherapy; 1994 Jul 02; 40(5):299-303. PubMed ID: 7956452
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF, Brown NP, Thornsberry C, Jones ME.
    Postgrad Med; 2008 Sep 02; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [Abstract] [Full Text] [Related]

  • 16. Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).
    Gales A, Sader H, Jones RN, SENTRY Participants Group (Latin America).
    Antimicrob Agents Chemother; 2001 May 02; 45(5):1463-6. PubMed ID: 11302811
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae.
    Kakinuma Y, Maeda Y, Mason C, Goldsmith CE, Coulter WA, Matsuda M, Dooley JS, Lowery CJ, Moore JE.
    Br J Biomed Sci; 2012 May 02; 69(3):123-5. PubMed ID: 23057160
    [Abstract] [Full Text] [Related]

  • 18. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709
    [Abstract] [Full Text] [Related]

  • 19. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K, Ogihara H, Ohno I, Shirato K.
    Jpn J Antibiot; 1997 Sep 17; 50(9):768-75. PubMed ID: 9394237
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan 17; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.